Smart for Life (SMFL) Competitors

$3.06
+0.06 (+2.00%)
(As of 05/17/2024 ET)

SMFL vs. AKAN, AMPE, ATHX, APVO, SIENQ, PKBO, MOTS, NVTA, ACORQ, and SXTC

Should you be buying Smart for Life stock or one of its competitors? The main competitors of Smart for Life include Akanda (AKAN), Ampio Pharmaceuticals (AMPE), Athersys (ATHX), Aptevo Therapeutics (APVO), Sientra (SIENQ), Peak Bio (PKBO), Motus GI (MOTS), Invitae (NVTA), Acorda Therapeutics (ACORQ), and China SXT Pharmaceuticals (SXTC). These companies are all part of the "medical" sector.

Smart for Life vs.

Smart for Life (NASDAQ:SMFL) and Akanda (NASDAQ:AKAN) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations, valuation and community ranking.

Smart for Life received 1 more outperform votes than Akanda when rated by MarketBeat users.

CompanyUnderperformOutperform
Smart for LifeOutperform Votes
1
100.00%
Underperform Votes
No Votes
AkandaN/AN/A

28.4% of Smart for Life shares are held by institutional investors. Comparatively, 1.0% of Akanda shares are held by institutional investors. 31.7% of Smart for Life shares are held by insiders. Comparatively, 20.4% of Akanda shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Akanda has a net margin of 0.00% compared to Smart for Life's net margin of -188.32%.

Company Net Margins Return on Equity Return on Assets
Smart for Life-188.32% N/A -75.82%
Akanda N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Smart for Life
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Akanda
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

In the previous week, Akanda had 1 more articles in the media than Smart for Life. MarketBeat recorded 2 mentions for Akanda and 1 mentions for Smart for Life. Smart for Life's average media sentiment score of 0.54 beat Akanda's score of 0.20 indicating that Smart for Life is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Smart for Life
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Akanda
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Smart for Life has a beta of 0.89, indicating that its share price is 11% less volatile than the S&P 500. Comparatively, Akanda has a beta of 1.57, indicating that its share price is 57% more volatile than the S&P 500.

Smart for Life has higher revenue and earnings than Akanda.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Smart for Life$17.77M0.02-$29.98M-$1.12 thousand0.00
Akanda$2.16M0.71-$32.28MN/AN/A

Summary

Smart for Life beats Akanda on 6 of the 11 factors compared between the two stocks.

Get Smart for Life News Delivered to You Automatically

Sign up to receive the latest news and ratings for SMFL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SMFL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SMFL vs. The Competition

MetricSmart for LifeMedicinals & botanicals IndustryMedical SectorNASDAQ Exchange
Market Cap$337,000.00$1.30B$5.16B$7.96B
Dividend YieldN/A2.52%43.85%3.91%
P/E Ratio0.005.53125.8015.24
Price / Sales0.0210.722,367.6177.84
Price / CashN/A197.3236.3731.98
Price / Book-0.012.025.744.76
Net Income-$29.98M-$165.47M$105.71M$217.17M
7 Day Performance-8.66%-0.66%1.39%2.90%
1 Month Performance-5.48%0.64%4.27%6.57%
1 Year Performance-97.98%5.00%7.71%10.17%

Smart for Life Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AKAN
Akanda
0 of 5 stars
$0.09
flat
N/A-83.9%$778,000.00$2.16M0.0046News Coverage
AMPE
Ampio Pharmaceuticals
0 of 5 stars
$0.27
flat
N/A-96.1%$308,000.00N/A-0.026Analyst Forecast
News Coverage
Gap Down
ATHX
Athersys
0 of 5 stars
$0.00
flat
N/A-99.5%$278,000.00$146,000.000.0024Analyst Forecast
Gap Up
APVO
Aptevo Therapeutics
0.1713 of 5 stars
$0.83
+2.5%
N/A-98.9%$356,000.00$3.11M0.0040Gap Up
SIENQ
Sientra
0 of 5 stars
$0.03
flat
N/AN/A$359,000.00$90.55M-0.01304Gap Down
PKBO
Peak Bio
0 of 5 stars
$0.01
flat
N/AN/A$195,000.00$610,000.000.0021
MOTS
Motus GI
2.0255 of 5 stars
$0.09
flat
$28.88
+33,089.7%
-99.3%$438,000.00$319,000.000.0015Earnings Report
News Coverage
Gap Down
NVTA
Invitae
1.4422 of 5 stars
$0.00
flat
$1.00
+166,566.7%
-99.8%$160,000.00$481.58M0.001,700Analyst Forecast
Gap Down
ACORQ
Acorda Therapeutics
0 of 5 stars
$0.38
+5.6%
N/AN/A$471,000.00$117.63M0.00102Gap Down
SXTC
China SXT Pharmaceuticals
0 of 5 stars
$1.11
+6.7%
N/A-80.3%$476,000.00$1.70M0.0078Positive News
Gap Down

Related Companies and Tools

This page (NASDAQ:SMFL) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners